Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Global profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32.

Torres-Martin M, Lassaletta L, de Campos JM, Isla A, Gavilan J, Pinto GR, Burbano RR, Latif F, Melendez B, Castresana JS, Rey JA.

PLoS One. 2013 Jun 11;8(6):e65868. doi: 10.1371/journal.pone.0065868. Print 2013.

2.

Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.

Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G, Wiemann S, Sahin O.

J Pathol. 2010 Jan;220(1):71-86. doi: 10.1002/path.2610.

PMID:
19768731
3.

Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.

Zehavi L, Avraham R, Barzilai A, Bar-Ilan D, Navon R, Sidi Y, Avni D, Leibowitz-Amit R.

Mol Cancer. 2012 Jul 2;11:44.

4.

Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.

Torres-Martin M, Lassaletta L, San-Roman-Montero J, De Campos JM, Isla A, Gavilan J, Melendez B, Pinto GR, Burbano RR, Castresana JS, Rey JA.

Int J Oncol. 2013 Mar;42(3):848-62. doi: 10.3892/ijo.2013.1798. Epub 2013 Jan 24.

5.

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113.

PMID:
23741026
6.

CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.

Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S.

Genes Chromosomes Cancer. 2009 Jul;48(7):615-23. doi: 10.1002/gcc.20669.

PMID:
19396864
7.
8.

MicroRNA expression profiling and target genes study in congenital microtia.

Li C, Hao S, Wang H, Jin L, Qing F, Zheng F, Zhang P, Chen L, Ma D, Zhang T.

Int J Pediatr Otorhinolaryngol. 2013 Apr;77(4):483-7. doi: 10.1016/j.ijporl.2012.12.011. Epub 2013 Jan 5.

PMID:
23294929
9.

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A.

J Pathol. 2009 Oct;219(2):214-21. doi: 10.1002/path.2586.

PMID:
19593777
10.

MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.

Sarver AL, Thayanithy V, Scott MC, Cleton-Jansen AM, Hogendoorn PC, Modiano JF, Subramanian S.

Orphanet J Rare Dis. 2013 Jan 11;8:7. doi: 10.1186/1750-1172-8-7.

11.

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.

Hepatology. 2008 Jun;47(6):1955-63. doi: 10.1002/hep.22256.

12.

Genome-wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster.

Torres-Martín M, Lassaletta L, de Campos JM, Isla A, Pinto GR, Burbano RR, Melendez B, Castresana JS, Rey JA.

Genes Chromosomes Cancer. 2015 Apr;54(4):197-209. doi: 10.1002/gcc.22232. Epub 2014 Dec 23.

PMID:
25533176
13.

Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.

Sand M, Skrygan M, Georgas D, Sand D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.

J Dermatol Sci. 2012 Dec;68(3):119-26. doi: 10.1016/j.jdermsci.2012.09.004. Epub 2012 Sep 13.

PMID:
23026055
14.

Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.

Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H.

Oncol Rep. 2010 Jun;23(6):1625-33.

PMID:
20428818
15.

Potential role of miR-9 and miR-223 in recurrent ovarian cancer.

Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, O' Leary J.

Mol Cancer. 2008 Apr 28;7:35. doi: 10.1186/1476-4598-7-35.

16.

Target identification of microRNAs expressed highly in human embryonic stem cells.

Li SS, Yu SL, Kao LP, Tsai ZY, Singh S, Chen BZ, Ho BC, Liu YH, Yang PC.

J Cell Biochem. 2009 Apr 15;106(6):1020-30. doi: 10.1002/jcb.22084.

PMID:
19229866
17.

Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.

Thayanithy V, Sarver AL, Kartha RV, Li L, Angstadt AY, Breen M, Steer CJ, Modiano JF, Subramanian S.

Bone. 2012 Jan;50(1):171-81. doi: 10.1016/j.bone.2011.10.012. Epub 2011 Oct 18.

18.

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.

van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.

Breast Cancer Res. 2012 Feb 21;14(1):R34.

19.

MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation.

Hamada N, Fujita Y, Kojima T, Kitamoto A, Akao Y, Nozawa Y, Ito M.

Neurochem Int. 2012 Jun;60(8):743-50. doi: 10.1016/j.neuint.2012.03.010. Epub 2012 Mar 24.

PMID:
22465943
20.

cDNA microarray analysis of vestibular schwannomas.

Welling DB, Lasak JM, Akhmametyeva E, Ghaheri B, Chang LS.

Otol Neurotol. 2002 Sep;23(5):736-48.

PMID:
12218628

Supplemental Content

Support Center